Peter Max

Mr. Peter Max is a Chairman at Clinical Laserthermia Systems AB, a Chief Executive Officer & Partner at Gemstone Capital ApS and a Partner at 1CT.
He is on the Board of Directors at Realfiction ApS, Sapphire Bioscience Holding ApS and Sophion Bioscience A/S.
Mr. Max was previously employed as a Chairman by Eltraco AS, an European Manager-ISP & Channel by ZyXEL Communications Corp., a Chief Executive Officer by Maxelle Management ApS, an Executive Vice President-Sales & Marketing by TDC A/S, a Chairman by One2one Network AS, a Chairman by BlueTags A/S, a Managing Director by Microsoft Corp., a Sales Manager by Apple Computer, Inc., and a Founder by Gemstone Partner Holding ApS.
He also served on the board at Realfiction Holding AB, Menucard ApS, A2I Systems A/S, HentTilbud ApS, Caramba Imaging ApS, Nh Gruppen Holding A/S, NetDesign A/S, Promentor Management AS, Damgaard Data A/S and Mindstorm Ltd. He received his undergraduate degree from Henley Business School Ltd. and an undergraduate degree from INSEAD.